BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare

BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare 
IRVINE, CA -- (Marketwired) -- 04/04/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
announced today that the Organization for Safety, Asepsis and
Prevention ("OSAP") has recently welcomed BIOLASE as a member of its
prestigious Super Sponsor partnership. 
OSAP's membership program unites a committed community of clinicians,
educators, consultants, associations, policy makers, and companies;
all who share OSAP's global vision of safe oral healthcare for people
everywhere. OSAP's Super Sponsors represent the highest level of
commitment to OSAP's mission and programs. 
Federico Pignatelli, Chairman and Chief Executive Officer, commented,
"We are very pleased to join in OSAP's efforts as advocates for safe
and infection-free dentistry. Cross-contamination in dental and
medical practices is a very real threat. As an example, approximately
7,000 patients in Tulsa, Oklahoma, are currently being urged to be
tested for hepatitis B and C and the human immunodeficiency virus,
which causes AIDS, after a patient who had no known risk factors
other than receiving dental treatment tested positive for hepatitis
C. With its laser light energy, BIOLASE's revolutionary WaterLase and
diode technologies can drastically reduce the risks of infection and
cross contamination that may be associated with the use of
traditional burs and root canal files." 
"BIOLASE is highly dedicated to educating patients and the medical
community on the advantages of its proprietary technology for
reducing cross contamination and significantly improving the dental
experience for the good of all patients," Pignatelli continued. "It
is tragic that approximately 100,000 people die in the United States
and 80,000 people die in Europe every year of infections contracted
in hospitals, medical practices, and heath care facilities,
particularly young children, the elderly, and persons with
compromised immune systems that are more likely to get an infection.
I believe it is paramount for leading dental and medical companies,
such as Henry Schein, Inc. (NASDAQ: HSIC), Sirona Dental Systems,
Inc. (NASDAQ: SIRO), and the Patterson Companies, Inc. (NASDAQ:
PDCO), to seriously commit to addressing this issue with maximum
urgency."  
Available to a limited number of companies, Super Sponsor status
offers the most inclusive relationship with OSAP, allowing access to
publications, meetings and other programs. Super Sponsors receive
strategic partner recognition through premium placement in all
materials and meetings, exclusive website recognition, an invitation
to participate in OSAP Board meetings, and other valuable benefits. 
"OSAP is the foremost authority in safe, infection-free oral
healthcare and it is essential that BIOLASE, as the world leader in
dental laser technology, join OSAP in the fight to ensure safe oral
healthcare and infection prevention worldwide," said William Brown,
VP of Sales and Marketing. "Our proprietary technology can greatly
reduce the risks of cross contamination in dental operatories
compared to traditional methods and, with our highly dedicated
200-plus employees and 22,000 dental lasers sold worldwide, access to
the information, resources, and educational tools available through
OSAP are immeasurable to BIOLASE."  
About OSAP
 The Organization for Safety, Asepsis and Prevention is
the world's leading membership association exclusively dedicated to
preventing disease transmission and ensuring the safe delivery of
oral healthcare for all. As a non-profit organization, OSAP helps
dental practitioners close the gap between policy and practice. Its
members include dental and other healthcare professionals,
consultants, researchers and non-governmental organizations,
manufacturing and distribution companies, policy makers and academia.
For more information, visit www.OSAP.org. 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products that are focused on
technologies that advance the practice of dentistry and medicine. The
Company's laser products incorporate over 315 patented and
patent-pending technologies designed to provide biologically
clinically superior performance with less pain and faster recovery
times. Its imaging products provide cutting-edge technology at
competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment. BIOLASE has sold more than 22,000 lasers. Other products
under development address ophthalmology and other medical and
consumer markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and
YouTube at www.youtube.com/biolasevideos.  
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
212-564-4700